Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding
Mutation of conserved cysteines in proteins of the Ly6 family cause human disease—chylomicronemia in the case of glycosylphosphatidylinositol-anchored HDL binding protein 1 (GPIHBP1) and paroxysmal nocturnal hemoglobinuria in the case of CD59. A mutation in a conserved cysteine in CD59 prevented the...
Main Authors: | Christopher M. Allan, Cris J. Jung, Mikael Larsson, Patrick J. Heizer, Yiping Tu, Norma P. Sandoval, Tiffany Ly P. Dang, Rachel S. Jung, Anne P. Beigneux, Pieter J. de Jong, Loren G. Fong, Stephen G. Young |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-07-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S002222752033594X |
Similar Items
-
An LPL–specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1[S]
by: Christopher M. Allan, et al.
Published: (2016-10-01) -
Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL[S]
by: Mikael Larsson, et al.
Published: (2017-09-01) -
Mobility of “HSPG-bound” LPL explains how LPL is able to reach GPIHBP1 on capillaries
by: Christopher M. Allan, et al.
Published: (2017-01-01) -
GPIHBP1, a GPI-anchored protein required for the lipolytic processing of triglyceride-rich lipoproteins
by: Anne P. Beigneux, et al.
Published: (2009-01-01) -
A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time[S]
by: Shwetha K. Shetty, et al.
Published: (2020-04-01)